Addressing the complexities of rare diseases, this book examines their epidemiology, molecular basis, and clinical management. It discusses diagnostic challenges, genetic testing methodologies, and personalized treatment strategies for rare genetic disorders. Collaborative networks, patient advocacy, and orphan drug development initiatives are also explored, emphasizing a multidisciplinary approach to improving outcomes for patients with rare diseases.